Biogen
Alzheimer's Dx Firms Aim to Take Advantage of Increased Testing Demand Following Leqembi Approval
Premium
Near term, CSF assays and PET imaging will likely remain the methods of choice for evaluating patients for the drug, but blood tests continue to gain traction.
Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium
The consortium aims to develop assays that can detect biomarkers of pulmonary fibrosis that can be used as early indicators of a treatment's activity.
Alzheimer's Researchers Propose Moving Towards Biological, Biomarker-Based Definition of Disease
Premium
Such an approach could be more specific for Alzheimer's than symptoms-based diagnoses while also allowing for earlier detection and treatment of the condition.
Theradiag Providing Kits to Biogen for Autoimmune Biosimilar Monitoring
Biogen will now be able to supply Lisa Tracker monitoring kits in the competitive tenders in which it participates in France and other parts of Europe.